e-learning
resources
Virtual 2020
Pre-Congress Content
New investigations of bronchiectasis and non-tuberculous mycobacteria
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Non-tuberculous mycobacteria: five year experience
M. Conceição (Viseu, Portugal), Â. Cunha (Viseu, Portugal), R. Ferro (Viseu, Portugal), S. Guerra (Viseu, Portugal), J. Correia (Viseu, Portugal), A. Reis (Viseu, Portugal), A. Torres (Viseu, Portugal)
Source:
Virtual Congress 2020 – New investigations of bronchiectasis and non-tuberculous mycobacteria
Session:
New investigations of bronchiectasis and non-tuberculous mycobacteria
Session type:
E-poster session
Number:
3342
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Conceição (Viseu, Portugal), Â. Cunha (Viseu, Portugal), R. Ferro (Viseu, Portugal), S. Guerra (Viseu, Portugal), J. Correia (Viseu, Portugal), A. Reis (Viseu, Portugal), A. Torres (Viseu, Portugal). Non-tuberculous mycobacteria: five year experience. 3342
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Related content which might interest you:
Nontuberculous mycobacteria in bronchiectasis: prevalence and patient characteristics
Source: Eur Respir J 2006; 28: 1204-1210
Year: 2006
Non-tuberculous mycobacteria
Source: Virtual Congress 2020 – Clinical grand round: revisiting current guidelines
Year: 2020
Pathogenicity of NTM: new developments
Source: Annual Congress 2007 - Nontuberculous mycobacteria (NTM): a slow-growing challenge
Year: 2007
Frequency of mycobacteriosis among the patients with positive cultures of nontuberculous mycobacteria (NTM) – 5 year study
Source: Eur Respir J 2004; 24: Suppl. 48, 190s
Year: 2004
Non-tuberculous mycobacteria (NTM) in bronchiectasis - a difficult management problem
Source: Eur Respir J 2003; 22: Suppl. 45, 515s
Year: 2003
Non-tuberculous mycobacterium infection in adult patients: a 10-year single-centre experience
Source: International Congress 2019 – Clinical investigations of non-TB mycobacterial infection
Year: 2019
Nontuberculous mycobacteria in non-HIV patients: epidemiology, treatment and response
Source: Eur Respir J 2004; 23: 741-746
Year: 2004
Treatment of pulmonary NTM infection: can it be done?
Source: Annual Congress 2007 - Nontuberculous mycobacteria (NTM): a slow-growing challenge
Year: 2007
Exceptional extra-pulmonary tuberculosis localization: a ten year series
Source: Annual Congress 2007 - Epidemiology of tuberculosis
Year: 2007
Non-tuberculous mycobacteria: how to treat these difficult infections
Source: International Congress 2018 – State of the art session: Respiratory infections
Year: 2018
A study of patients with pulmonary tuberculosis and confirmed coexistence of nontuberculous mycobacteria during treatment: Does the use of the additional acid-fast bacilli sputum test lead to shorter hospitalization?
Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 2
Year: 2014
A case of non-tuberculous mycobacteria disease
Source: Annual Congress 2010 - Infectious Diseases Grand Round: an interactive session
Year: 2010
Nontuberculous mycobacterial lung disease caused by
Mycobacterium parascrofulaceum
in an immunocompetent patient
Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 1
Year: 2014
Non-tuberculous mycobacteria effect in the diagnosis of latent tuberculosis infection in children
Source: Annual Congress 2010 - Nontuberculous mycobacterial infections and tuberculosis
Year: 2010
Pulmonary infection with nontuberculous mycobacteria: management and follow up of 5 infected patients
Source: Annual Congress 2009 - Treatment and prevention of lower respiratory tract infections
Year: 2009
Late Breaking Abstract - Use of non-tuberculous mycobacteria (NTM) specific antigens to detect NTM infection
Source: International Congress 2019 – The microbiome: novel data across respiratory diseases
Year: 2019
Non-tuberculous mycobacteria: preventing infection and reinfection
Source: International Congress 2019 – Respiratory infections: prevention is better than cure
Year: 2019
Clinical outcome of multiple nontuberculous mycobacteria infection among people with bronchiectasis in Taiwan: a cohort study
Source: Virtual Congress 2020 – New investigations of bronchiectasis and non-tuberculous mycobacteria
Year: 2020
The management of non-tuberculous mycobacteria
Source: International Congress 2016 – New therapies for chronic respiratory infections
Year: 2016
Nontuberculous mycobacteria (NTM) - a 15 year review from a single unit, 1986-2000
Source: Eur Respir J 2001; 18: Suppl. 33, 480s
Year: 2001
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept